ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

In Brief: Radiation Therapy Pioneer Juan Del Regato Dead At 90

July 16, 1999